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Objectives/Background: Efforts to control the global burden of tuberculosis (TB) epidemic
have now been jeopardized by the rapid evolution of drug-resistant Mycobacterium tuber-
culosis (MTB), which are resistant to one or more anti-TB drugs. Multidrug resistant (MDR)
TB in Ethiopia may be more prevalent than previously appreciated; thus, up-to-date
national drug resistance studies are critically needed. Therefore, this meta-analysis aimed,
first, to determine pooled prevalence of MDR TB among newly diagnosed and previously
treated TB cases, and second, to measure the association between previous anti-TB expo-
sure and acquisition of MDR-MTB infection.
Methods: PubMed and Embase databases were consulted. Studies that reported the preva-
lence of MDR TB among newly diagnosed and previously treated TB patients were selected.
Studies or surveys conducted at a national or subnational level, with reported MDR-TB
prevalence or sufficient data to calculate the prevalence, were considered for the analysis.
Two authors searched and reviewed the studies for eligibility and extracted the data in pre-
defined forms. Forest plots of all prevalence estimates were performed, and summary esti-
mates were also calculated using random effect models. Associations between previous TB
treatment and MDR-MTB infection were examined through subgroup analyses stratified by
new and previously treated patients.
Results: We identified 16 suitable studies, and found an overall prevalence of MDR TB of
1.7% (95% confidence interval 1.2–2.3%) among newly diagnosed and that of 14.1% (95%
confidence interval 10.9–17.2%) among previously treated TB patients, and the observed dif-
ference was statistically significant (p < .01). For the past 10 years, the overall MDR-TB
prevalence showed a stable time trend. There was an odds ratio of 8.1 (95% confidence
interval 7.5–8.7) for previously treated TB patients to develop an MDR-MTB infection com-
pared with newly diagnosed cases.f Medicine
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berculosis treatment: A systematic review andConclusion: The MDR-TB prevalence remains high, especially in previously treated TB cases.
Previous TB treatment was the most powerful predictor for MDR-MTB infection. Hence,
strict compliance with anti-TB regimens and improving case detection rate are urgently
needed to tackle the problem.Conflicts of interest
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